We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 56.94%
This Fund
S&P 500
This Quarter Est. Return
+31.2%
1 Year Est. Return
+56.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$849M
Cap. Flow
+$57M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.1%
Holding
957
New
177
Increased
251
Reduced
333
Closed
196

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.7M
2
META icon
Meta Platforms (Facebook)
META
+$41.2M
3
MRK icon
Merck
MRK
+$26.1M
4
INTU icon
Intuit
INTU
+$24.7M
5
AZN icon
AstraZeneca
AZN
+$23.6M

Top Sells

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$29.3M
2
QCOM icon
Qualcomm
QCOM
+$28.6M
3
FTNT icon
Fortinet
FTNT
+$26.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$22.1M
5
LLY icon
Eli Lilly
LLY
+$20.8M

Sector Composition

Rank Sector Weight
1 Technology 34.25%
2 Financials 12.04%
3 Healthcare 11.39%
4 Industrials 10.72%
5 Consumer Discretionary 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBRX icon
226
ImmunityBio
IBRX
$8.38B
$4.81M 0.09%
549,126
-608,032
-53% -$4.6M
CALM icon
227
Cal-Maine
CALM
$3.46B
$4.81M 0.09%
59,661
+41,318
+225% +$3.19M
BEPC icon
228
Brookfield Renewable
BEPC
$5.71B
$4.81M 0.09%
129,478
-107,092
-45% -$4.15M
GE icon
229
GE Aerospace
GE
$336B
$4.74M 0.09%
12,687
+756
+6% +$237K
OPY icon
230
Oppenheimer Holdings
OPY
$1.32B
$4.71M 0.09%
44,658
+8,136
+22% +$828K
RAL
231
Ralliant Corp
RAL
$7.44B
$4.67M 0.09%
63,379
-33,910
-35% -$1.89M
NAVN
232
Navan Inc
NAVN
$5.47B
$4.65M 0.08%
+203,292
New +$3.72M
CSTM icon
233
Constellium
CSTM
$3.55B
$4.62M 0.08%
145,101
-94,400
-39% -$3.05M
VITL icon
234
Vital Farms
VITL
$418M
$4.61M 0.08%
396,630
+254,965
+180% +$2.84M
VTRS icon
235
Viatris
VTRS
$19B
$4.59M 0.08%
289,259
+8,102
+3% +$126K
UNFI icon
236
United Natural Foods
UNFI
$2.68B
$4.53M 0.08%
99,132
+76,237
+333% +$3.78M
EME icon
237
Emcor
EME
$34.4B
$4.52M 0.08%
5,450
+2,736
+101% +$2.31M
VERX icon
238
Vertex
VERX
$1.99B
$4.52M 0.08%
393,508
+5,402
+1% +$67.5K
DHR icon
239
Danaher
DHR
$141B
$4.51M 0.08%
23,686
-3,209
-12% -$583K
EOG icon
240
EOG Resources
EOG
$77.3B
$4.51M 0.08%
34,760
-8,472
-20% -$1.15M
ACN icon
241
Accenture
ACN
$113B
$4.44M 0.08%
35,710
+33,308
+1,387% +$5.78M
HL icon
242
Hecla Mining
HL
$13.3B
$4.44M 0.08%
287,906
+246,946
+603% +$4.34M
SNX icon
243
TD Synnex
SNX
$21.5B
$4.37M 0.08%
+16,338
New +$3.94M
NWPX icon
244
NWPX Infrastructure Inc
NWPX
$1.01B
$4.35M 0.08%
+28,979
New +$3.17M
MDLZ icon
245
Mondelez International
MDLZ
$79.7B
$4.27M 0.08%
73,762
-42,125
-36% -$2.54M
ZBIO
246
Zenas BioPharma
ZBIO
$2.03B
$4.24M 0.08%
167,145
+137,533
+464% +$2.73M
UTHR icon
247
United Therapeutics
UTHR
$21.3B
$4.14M 0.08%
7,649
+4,544
+146% +$2.56M
CSX icon
248
CSX Corp
CSX
$90.7B
$4.13M 0.08%
86,872
+57,291
+194% +$2.59M
NFLX icon
249
Netflix
NFLX
$322B
$4.12M 0.08%
57,698
+46,965
+438% +$4.14M
CRVL icon
250
CorVel
CRVL
$3.5B
$4.12M 0.08%
65,893
-22,162
-25% -$1.29M
8 9
10
11 12

Similar funds

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Voleon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
  • Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
  • Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
  • Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
  • Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
  • Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
  • Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.